Welcome to our dedicated page for DKDCA news (Ticker: DKDCA), a resource for investors and traders seeking the latest updates and insights on DKDCA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DKDCA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DKDCA's position in the market.
OneMedNet Corporation has appointed David Gascoigne as Chief Operating Officer, effective immediately. With over 30 years of experience in the life sciences sector, Gascoigne has held senior roles at notable firms such as IQVIA and Accenture. His expertise in analytics and technology is expected to drive business growth for OneMedNet. The company, known for its OneMedNet iRWD solution, specializes in regulatory-grade imaging real-world data. This appointment follows a recent business combination agreement with Data Knights Acquisition Corp. (Nasdaq:DKDCA), enhancing its market position.
OneMedNet Corporation and Data Knights Acquisition Corp. have filed a registration statement for their proposed business combination, with completion expected in H2 2022, subject to shareholder approval and SEC clearance. The transaction values OneMedNet at a pro forma enterprise value of $317 million. In Q1 2022, OneMedNet reported $233,966 in net sales, a 34% increase year-over-year. This merger aims to enhance data solutions for healthcare providers, leveraging OneMedNet's regulatory-grade imaging real-world data capabilities.
Data Knights Acquisition Corp. (NASDAQ: DKDCA, DKDCW) has deposited $1,150,000 into its Trust account, providing $0.10 per public share, to extend its deadline for the initial business combination with OneMedNet Corporation by three months, from May 11, 2022, to August 11, 2022. This extension allows additional time to finalize the merger, previously announced on April 25, 2022. Data Knights is a special purpose acquisition company focused on merging with tech or software firms.
